NCT01159119View on ClinicalTrials.gov

A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal Pain

PHASE1TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 2, 2010

Primary Completion Date

July 1, 2011

Study Completion Date

July 1, 2011

Conditions
Chronic Pancreatitis
Interventions
DRUG

EUR-1066-A

Eur-1066 capsules taken daily for 28 days either during treatment period 1 or treatment period 3.

DRUG

Zenpep

Capsules taken for daily for 28 days during treatment period 2

DRUG

EUR-1066-B

Eur-1066 capsules taken daily for 28 days either during treatment period 1 or treatment period 3.

Trial Locations (1)

32611

University of Florida, Gainesville

Sponsors
All Listed Sponsors
collaborator

University of Florida

OTHER

lead

Forest Laboratories

INDUSTRY